ArticleDiabetologia2022

Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer's disease risk in the general population: a Mendelian randomisation study.

Jie Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.